Breaking News, Collaborations & Alliances

Asahi Kasei Bioprocess America, GeminiBio Partner to Advance Inline Buffer Formulation

Partnership will be a catalyst for innovation at both companies, driving new industry standards.

Asahi Kasei Bioprocess America, a subsidiary of Japanese multinational company Asahi Kasei, and GeminiBio, entered into a strategic partnership to advance the application of inline buffer formulation (IBF) in the biopharmaceutical industry. The companies will combine two high-efficiency solutions for buffer management for biopharmaceutical manufacturers in one package. Asahi Kasei Bioprocess will leverage its expertise in IBF and its MOTIV system, and GeminiBio will use its bioprocess liquid ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters